SCHEMBL1897112

SCHEMBL1897112

O=C(Nc1ccccc1)N1C=COc2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 3/20 0.46
TP53 P04637 3/20 0.46
RAB9A P51151 3/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.44
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NAMPT P43490 7/20 0.40
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
TAS1R2 Q8TE23 2/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171950 0.82 HSD17B3 (0.36) SMN1; SMN2NPC1RAB9ATRPM8GAA
SCHEMBL1897109 0.81 GAA (0.43) SMN1; SMN2NPC1RAB9AGAAMAPT
SCHEMBL6173888 0.78 HSD17B3 (0.35) NPC1RAB9AMAPTHPGDKDM4E
SCHEMBL30025878 0.74 MEN1 (0.42) SMN1; SMN2NPC1RAB9A
SCHEMBL10576926 0.70 MAOA (0.35) SMN1; SMN2NPC1RAB9AGAAHPGD
SCHEMBL10226370 0.69 NPC1 (0.78) SMN1; SMN2NPC1TP53RAB9ANAMPT
SCHEMBL10370451 0.65 MAOA (0.35) SMN1; SMN2NPC1TP53RAB9AMAPT
SCHEMBL27529391 0.65 MAOA (0.31)
SCHEMBL4420044 0.64 NAMPT (0.44) SMN1; SMN2NPC1RAB9AMAPTNAMPT
SCHEMBL8553422 0.64 CYP2C9 (0.45) SMN1; SMN2NPC1TP53RAB9ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947833-B2 methods that are useful in the preparation of amidophenyl-sulfonylamino-quinoxaline compounds CCK2 modulators are disclosed by sulfonylation JANSSEN PHARMACEUTICA NV (BE) 2011-05-24 US disclosed